This Slideshare introduces CMAP-Pro to Practice Managers and Administrators explaining how the device helps doctors improve outcomes for patients with soft tissue injuries, while increasing profit for the practice, and also shares 5 keys to easy implementation into your practice workflow. TO SEE TO LIVE PRESENTATION GO TO: https://nvmanagementcorp.com/cmap-perfect-auto-webinaripqpl961
The CMAP-Pro protocols capture the activity and function of specific muscle and nerve groups involved in soft tissue injuries.
FDA-approved in 2012, CMAP-Pro patient results have been validated through published clinical studies and featured in several peer reviewed journal articles.
A study was conducted with 114 consecutive patients with musculoskeletal pain claims results indicated a 6.9 times increase in the odds of case closure when there was concordance between CMAP-Pro results & the physicians independent diagnosis.
CMAP-Pro is indicated for use with:
Sprains or strains of the spine or limbs after 4 weeks without improvement; Upon consideration of upper or lower extremities; upon diagnosis of Carpal Tunnel Syndrome / Median Nerve Dysfunction; Upon diagnosis of Fibromyalgia, Myofascial Pain, Chronic Fatigue Syndrome; At symptom onset of Cumulative trauma disorder; Prior to or as part of the evaluation of Agreed Medical Evaluation / Qualified Medical Evaluation / Independent Medical Evaluation; At onset of new claim of patients with recurrent soft tissue claims; All neck and back cases when surgery considered; when symptoms do not match the description of injury/accident (ambiguous etiology); when trying to determine whether or not an injury is work related (causation analysis); when presence of pathology is in doubt (claims of an uncertain nature); to determine permanent and stationary (P&S) status or maximum medical improvement (MMI) in unexplained delayed return to work (RTW) claims; Prior to release of patient to modified duty to objectively define transitional/modified duties.
Look for a dynamic, dedicated individual? Then, look NO further! I also poses over 8 years Cerner I.S. experience and am looking for that great fit at a long-term opportunity.
10 Things an Operations Supervisor can do Today to Improve ReliabilityRicky Smith CMRP, CMRT
Continuing the series that started with maintenance technicians and supervisors, if you are new to the position of Operations Supervisor, what are some of the things you can begin working on immediately to improve reliability within the area you work?
Look for a dynamic, dedicated individual? Then, look NO further! I also poses over 8 years Cerner I.S. experience and am looking for that great fit at a long-term opportunity.
10 Things an Operations Supervisor can do Today to Improve ReliabilityRicky Smith CMRP, CMRT
Continuing the series that started with maintenance technicians and supervisors, if you are new to the position of Operations Supervisor, what are some of the things you can begin working on immediately to improve reliability within the area you work?
Turning Price Transparency Into a Competitive Advantage in the Age of Consume...Megan Williams
-What you should do if you’re still struggling with price transparency compliance
-The role of margin insight and cost accounting
-Helpful tools in price estimation and analytics
-Learn how to prepare for a post-price transparency world
-Discover actionable best practices for your future price transparency initiatives
-Refine your tech strategy
Business case study for the Runsafe program at the University of California at San Francisco (UCSF) to explore the commercial viability of their technology.
Streamlining Your Medical Practice for Profitability and SuccessConventus
Conventus webinar video providing key success strategies and tactics for improving productivity, profitability, and patient care. The one-hour video features host Susan Lieberman of Conventus and Stevie Davidson of Health Informatics Consulting.
How to build a centralized healthcare call centerNisos Health
Read our views on how to build a centralized healthcare call center. This is how we have built, operated and transferred patient contact centers for our healthcare customers.
ISO 9001:2008 is a quality management system standard, first published in 1987 by ISO (International Organization for Standardization). This standard is designed to help organizations ensure that they meet all requirements of customers and stakeholders.
Here we analyze a case and answering some following questions about mission critical and safety critical system, importance of certification, business strategy etc.
Here is the case:
The Johns Hopkins Cancer Center, nationally recognized as one of the leading cancer centers in the United States, is a major InterSystems customer.
The hospital implemented an advanced, multifunctional oncology clinical information system based on Caché.
Preparation is the Key to Meaningful Use SuccessIatric Systems
To help hospitals and eligible providers navigate the changing landscape of Meaningful Use, we created an educational webcast.
This session provides valuable Meaningful Use information including:
• Recent updates from CMS
• Keys to audit preparation
• How to identify and correct gaps in your Meaningful Use plan
• How to ensure IMO data terminology mapping is completed accurately and on-time
Ancillary Revenue Solutions for Clinics Paradigm ShiftArney Benson
While clinics and Doctors look to survive and thrive in the Practice arena, it doesn't look good ! I/we have 24 Verticals all under 1 Umbrella giving you the advantage to all others.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Turning Price Transparency Into a Competitive Advantage in the Age of Consume...Megan Williams
-What you should do if you’re still struggling with price transparency compliance
-The role of margin insight and cost accounting
-Helpful tools in price estimation and analytics
-Learn how to prepare for a post-price transparency world
-Discover actionable best practices for your future price transparency initiatives
-Refine your tech strategy
Business case study for the Runsafe program at the University of California at San Francisco (UCSF) to explore the commercial viability of their technology.
Streamlining Your Medical Practice for Profitability and SuccessConventus
Conventus webinar video providing key success strategies and tactics for improving productivity, profitability, and patient care. The one-hour video features host Susan Lieberman of Conventus and Stevie Davidson of Health Informatics Consulting.
How to build a centralized healthcare call centerNisos Health
Read our views on how to build a centralized healthcare call center. This is how we have built, operated and transferred patient contact centers for our healthcare customers.
ISO 9001:2008 is a quality management system standard, first published in 1987 by ISO (International Organization for Standardization). This standard is designed to help organizations ensure that they meet all requirements of customers and stakeholders.
Here we analyze a case and answering some following questions about mission critical and safety critical system, importance of certification, business strategy etc.
Here is the case:
The Johns Hopkins Cancer Center, nationally recognized as one of the leading cancer centers in the United States, is a major InterSystems customer.
The hospital implemented an advanced, multifunctional oncology clinical information system based on Caché.
Preparation is the Key to Meaningful Use SuccessIatric Systems
To help hospitals and eligible providers navigate the changing landscape of Meaningful Use, we created an educational webcast.
This session provides valuable Meaningful Use information including:
• Recent updates from CMS
• Keys to audit preparation
• How to identify and correct gaps in your Meaningful Use plan
• How to ensure IMO data terminology mapping is completed accurately and on-time
Ancillary Revenue Solutions for Clinics Paradigm ShiftArney Benson
While clinics and Doctors look to survive and thrive in the Practice arena, it doesn't look good ! I/we have 24 Verticals all under 1 Umbrella giving you the advantage to all others.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
For those battling kidney disease and exploring treatment options, understanding when to consider a kidney transplant is crucial. This guide aims to provide valuable insights into the circumstances under which a kidney transplant at the renowned Hiranandani Hospital may be the most appropriate course of action. By addressing the key indicators and factors involved, we hope to empower patients and their families to make informed decisions about their kidney care journey.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...Kumar Satyam
According to the TechSci Research report titled “India Diagnostic Labs Market Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2019-2029,” the India Diagnostic Labs Market was valued at USD 16,471.21 million in 2023 and is projected to grow at an impressive compound annual growth rate (CAGR) of 11.55% through 2029. This significant growth can be attributed to various factors, including collaborations and partnerships among leading companies, the expansion of diagnostic chains, and increasing accessibility to diagnostic services across the country. This comprehensive report delves into the market dynamics, recent trends, drivers, competitive landscape, and benefits of the research report, providing a detailed analysis of the India Diagnostic Labs Market.
Collaborations and Partnerships
Collaborations and partnerships among leading companies play a pivotal role in driving the growth of the India Diagnostic Labs Market. These strategic alliances allow companies to merge their expertise, strengthen their market positions, and offer innovative solutions. By combining resources, companies can enhance their research and development capabilities, expand their product portfolios, and improve their distribution networks. These collaborations also facilitate the sharing of technological advancements and best practices, contributing to the overall growth of the market.
Expansion of Diagnostic Chains
The expansion of diagnostic chains is a driving force behind the growing demand for diagnostic lab services. Diagnostic chains often establish multiple laboratories and diagnostic centers in various cities and regions, including urban and rural areas. This expanded network makes diagnostic services more accessible to a larger portion of the population, addressing healthcare disparities and reaching underserved populations. The presence of diagnostic chain facilities in multiple locations within a city or region provides convenience for patients, reducing travel time and effort. A broader network of labs often leads to reduced waiting times for appointments and sample collection, ensuring that patients receive timely and efficient diagnostic services.
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant driver for the demand for diagnostic lab services. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require regular monitoring and diagnostic testing for effective management. The rise in chronic diseases necessitates the use of advanced diagnostic tools and technologies, driving the growth of the diagnostic labs market. Additionally, early diagnosis and timely intervention are crucial for managing chronic diseases, further boosting the demand for diagnostic lab services.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
2. My Promise To You:
• I'll show you exactly how the CMAP-Pro (created
by docs & for docs) can help improve your patient
outcomes & increase your profits...without
capital expense or hidden costs, AND
• How easy it is to implement this device into your
practice’s workflow
5. Your Attention Please...
• Silence cell phones
• If you're a Practice Manager or Administrator
and you're serious about improving outcomes
of your STI claims and increasing the bottom
line, the next 30 minutes will be very valuable
to you
6. Jennifer Anderson, Practice Manager
Presenter -
Over 15 years experience in a variety of healthcare
specialties and business startups.
Passionate about the design and implementation of
clinical procedures and operations, culture shifts,
training programs, medical equipment and safety
policy resulting in over $2.6M in combined practice
savings and profit.
Lead singer of a local rock band
Still happily married to my husband of 15 years after
overcoming the challenges of my his 5 year addiction
to pain medication that came as a direct result of a
misdiagnosed soft tissue injuries following a serious
accident and unnecessary surgery.
7. Meet the Inventor of CMAP-Pro
Dr. Marco Vitiello…Board Certified
Physician in Internal, Emergency and
Forensics Medicine
Fellow of the Academy of Forensics
CMAP-Pro (Comprehensive Muscular
Activity Profiler) = combining 4 AMA
accepted protocols into one unique
test, created by doctors, for doctors
Had 4 large Occupational Health and
Urgent Care facilities in Florida
8. Imagine What Your Practice Would Be Like If:
• Your providers could objectively and more accurately
diagnose and treat soft tissue injuries, help patients avoid
unnecessary surgeries, and improve patient outcomes
• You could avoid the usual headaches of new technology
installation like staff training or remodeling clinical space
• You could drive an extra $22,500 or more to the practice’s
bottom line
• You could do all this without any out-of-pocket expense
to the practice, it’d be a WIN-WIN-WIN for patients,
providers and administrators!
9. What About RESULTS…PROOF?
Here are a some to start with…
• CMAP-Pro patient results have been validated through published
clinical studies and featured in several peer reviewed journal
articles
• We know that a facility with 25 Soft Tissue Injury (STI) patients can
expect approximately $22,500/month in reimbursement from
revenue share
• A study was conducted with 114 consecutive patients with
musculoskeletal pain claims results indicated a 6.9 times increase in
the odds of case closure when there was concordance between
CMAP-Pro results & the physicians independent diagnosis
10. CMAP-Pro Feasibility Study – DMEC Article, December 2012
Focus on neck/upper extremity/lower back cases
Collection of data at test administration
Collection of data 6-9 months following test to compare results
Used CMAP-ProNo CMAP-Pro
11. Getting Results for Your Practice
• In the next few minutes, I'll walk you through
the Direct Placement program and process to
get these results for your practice.
• This program is only available for practices
who see 25 or more STI patients per month.
12. What We'll Cover in Today’s Webinar:
• Finding #1: How the CMAP-Pro helps to
improve patient outcomes
• Finding #2: How your practice can increase
profits with the CMAP-Pro
• Finding #3: How CMAP-Pro is a breeze to
implement because all the heavy lifting is
done for you
13. Finding #1:
How Did One Doctor Innovate & Improve
Traditional STI Tools & Protocols?
14.
15. • Combines American Medical Association (AMA) approved tests:
Functional Capacity Evaluations
Range of Motion
Pinch, lift and grip strength measurements
Spatial high resolution EMG
Gathers data while muscles are in motion
Conducts bilateral evaluations to enhance, confirm or identify issues not
always available when using X-rays, MRIs or CTs
16.
17. How CMAP-Pro Can Help Your Practice
Improve Patient Outcomes: Finding #1
For the first time,
Objective sEMG Data could be obtained to more
accurately diagnose soft tissue injuries
Assess Acute vs. Chronic pain (0-90 days)
Confirm patient’s “Sincerity of Effort”
26. Yes, Your Practice CAN Increase Profits
With CMAP-Pro: Finding #2
• All about how your practice can increase profits
with the CMAP-Pro
• Technology often overpromises and claims are
too good to be true -- especially when it comes to
profits
• Actually, incorporating the CMAP-Pro is a true
WIN-WIN-WIN, with no hidden costs, just better
patient care...and yes, profits
• What do I mean?
27. Increase Profits with CMAP-Pro:
Finding #2
• Reimbursement = $300-$600 (avg. $450) per protocol
(Medicare v. Commercial Insurance)
• Average patient requires 2 CMAP-Pro protocols
• 25 Soft Tissue Injury patients/month = $22,500/month
• No capital expenditure
28. CMAP-Pro Workflow
Your Provider identifies an STI patient and
orders CMAP-Pro assessment
Patient gets tested (15-45 mins) by a CMAP-
Pro Certified Technician
Assessment is streamed to CMAP-Pro-
trained, board certified Physician for review
and signature
Treating provider electronically receives the
report and uses the objective data to
augment his or her clinical expertise,
diagnosis, & treatment plan
29. Direct Placement Model
• Work = Remuneration
50/50 Revenue-share model (Stark Law-compliant)
3rd party billing contract for pre-authorization, billing,
collections, appeals, & patient deductibles
Lease device fee / per protocol
Electrodes
30. Let me ask you a question...
Are you enjoying the webinar so far?
32. CMAP-Pro - EASY Implementation
Finding #3
• All about how CMAP-Pro is EASY to introduce and
implement into your existing workflows.
• Most Practice Managers know from experience
that implementing new technologies into a
facility always seems to take a lot of time and
resources
• Actually, I’ll you how implementing the CMAP-Pro
into your practice is a “no-brainer”
• 5 Keys to make it easy…
33. Key #1: Space for Testing
Only need a 10' x 10' for CMAP-Pro testing equipment
34. Key #2: Utilization
CMAP-Pro is portable, so you can move it around to
make the most of your underutilized clinical space
35. Key #3: Training
FREE - CMAP-Pro Training and Certification
Up to 3 clinical support staff per location
36. Key #4: Reimbursement
Pre-authorizations and billing is done for you by
trusted 3rd-party billing company
37. Key #5: Scheduling
Book STI appointments back-to-back on a designated
“CMAP-Pro day-of-the-week” OR
Just fill in existing gaps in your schedule
38. We've Covered:
Finding #1: How the CMAP-Pro Improves
Patient Outcomes
Finding #2: How your practice can increase
profits with the CMAP-Pro
Finding #3: 5 Pointers for EASY Implementation
CMAP-Pro into Your Practice
39. So who wants to take things
to the Next Level?
(Put in the Q&A box, "I'm ready!!”)
41. Your CMAP-Pro Consultation is All About…
Getting answers to of all of your questions and
see if CMAP-Pro is a good fit for your practice
Determining if your practice is a candidate for
Direct Placement of CMAP-Pro (# of STI’s,
space, staff)
Giving you all the information and resources
you need to make the best decision for your
practice
48. What is the “Value” of CMAP-Pro?
• If you paid $1M for all this (and only saw 25 STI
patients/month) you’d have a 24% return on your
investment
• If you paid $2M for all this (and only saw 25 STI
patients/month) you’d have a 12% return on your
investment
• If you paid $3M for all this (and only saw 25 STI
patients/month) you’d have a 8% return on your
investment
52. 30 min Provider Phone Consultation
with a CMAP-Pro
Board Certified Physician
“It takes time to persuade men to do even what is for
their own good.” -Thomas Jefferson
53. Unlimited Phone Support for
CMAP-Pro Implementation
from a Seasoned Practice Manager
($3,000/yr Value)
54. What You're Going To Get:
• Isometric Functional Capacity Evaluation (FCE) Measurement Sensors for Lift,
Pinch, and Grip Strength, and Muscle Fatigue ($ Value)
• Range of Motion (ROM) Gyroscopic Dual Inclinometers - Detect relative
motion between two points, capabilities and limitations regarding multiple
movements including flexion/extension, inversion/eversion and rotation ($
Value)
• High Resolution Spatial Electromyography (sEMG) - extracts meaningful data
via proprietary lead arrays, provides objective data to assess the presence
and type of muscle firing, maintains high Signal to Noise ratio (S/N), samples
at a rate of 2000 Hz ($ Value)
• CMAP-Pro POD - Gathers data connecting all sensors, motion trackers, and
electrodes; data is streamed wirelessly to a custom designed all-in-one
computer with a user friendly interface; rechargeable battery lasts up to 12
hours ($ Value)
• CMAP-Pro Data Analysis - Data is securely transmitted (HIPAA compliant) for
analysis and interpretation by a board certified physician ($ Value)
Total Value: How much would this be worth to your practice?
55.
56. Won’t miss anything Comprehensive No-Cost
Analysis of How Your
Practice Looks Online
Make it easy for you
to share
57. And so the time has come…
Thank you for joining me today!
58. But if You’re Really Serious About
Improving Patient Outcomes and
Increasing Your Practice’s Revenue
by $22,500+ per month…
Check Your Calendar NOW
And Get Your
“CMAP-Pro Consultation”
Today
Editor's Notes
The company is committed to really making a positive impact on the diagnosis and treatment of soft tissue injuries
Now take a look at these muscle activity patterns from an actual CMAP-Pro evaluation…
Get your customized closes from the “Perfect Webinar Closes” Output in the Wizard